Alliance will provide insight, education, and training opportunities to pharmaceutical and life sciences professionals. CRANBURY, N.J.–(BUSINESS WIRE)–#ClinicalPractice—Drug Topics®, a leading
U.S. FDA has authorized mRNA vaccine against COVID-19 for emergency use as total of 200 million doses ordered by the U.S government to date, with an option to purchase up to an additional 300 million doses, while approximately 20 million doses will be delivered by the end of December 2020.
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
LUXEMBOURG–(BUSINESS WIRE)–The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need